ROYAL BANK OF CANADA - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$10,255,000
+576.9%
221,330
+256.1%
0.00%
+300.0%
Q1 2019$1,515,000
+225.1%
62,157
+90.1%
0.00%
Q4 2018$466,000
+166.3%
32,704
+183.6%
0.00%
Q3 2018$175,000
+2.3%
11,530
+13.7%
0.00%
Q2 2018$171,000
-19.0%
10,138
-21.3%
0.00%
Q1 2018$211,000
+379.5%
12,874
+266.7%
0.00%
Q4 2017$44,000
-80.8%
3,511
-81.1%
0.00%
Q3 2017$229,000
+2762.5%
18,620
+1889.3%
0.00%
Q2 2017$8,000
-87.7%
936
-87.1%
0.00%
Q1 2017$65,000
-83.4%
7,264
-83.7%
0.00%
Q4 2016$392,000
+1407.7%
44,579
+1070.1%
0.00%
Q3 2016$26,000
-35.0%
3,810
-66.3%
0.00%
Q2 2016$40,000
-11.1%
11,310
-27.5%
0.00%
Q1 2016$45,000
-70.2%
15,590
-56.1%
0.00%
Q4 2015$151,000
-30.7%
35,535
-25.8%
0.00%
Q3 2015$218,000
+194.6%
47,875
+363.9%
0.00%
Q2 2015$74,0000.0%10,321
-36.4%
0.00%
Q2 2014$74,000
+362.5%
16,225
+377.2%
0.00%
Q1 2014$16,000
-87.4%
3,400
-86.6%
0.00%
Q4 2013$127,000
-21.1%
25,336
-2.4%
0.00%
Q3 2013$161,000
+66.0%
25,960
+22.1%
0.00%
Q2 2013$97,00021,2540.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
BVF INC/IL 9,719,589$60,456,00010.40%
KOPP INVESTMENT ADVISORS LLC 2,808,537$17,470,0006.42%
Redmile Group, LLC 3,669,593$22,825,0003.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,585,406$65,841,0003.06%
QVT Financial LP 2,878,600$17,905,0001.22%
APEX CAPITAL, LLC 2,500,000$15,550,0001.12%
FBR & Co. 113,500$706,0001.07%
Artal Group S.A. 3,000,000$18,660,0000.61%
Perimeter Capital Partners, LLC 486,478$3,026,0000.56%
Orbimed Advisors 4,831,600$30,053,0000.54%
View complete list of ARRAY BIOPHARMA INC shareholders